Postura IMS sobre Testosterona y su relación con el Cáncer de mama
Postura de la Comisión de IMS sobre el uso de la Testosterona en la Menopausia
Postura de la Comisión de IMS sobre el uso de la Testosterona en la Menopausia
Declaración conjunta del Royal College of Obstetricians and Gynecologists & British Menopause Society en respuesta al estudio de Lancet sobre el uso de TRH y el riesgo de cáncer de seno.
+Más info Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding
MERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE–2017 UPDATE Rhoda H. Cobin, MD, MACE1; Neil F. Goodman, MD, FACE2; on behalf of the AACE Reproductive Endocrinology Scientific Committee
En México, el cáncer de ovario en todos los grupos de edad, representa alrededor de 5% de los diagnósticos de cáncer y el 21% de los cánceres ginecológicos (i). La presencia de los genes BRCA1 y BRCA2 aumentan el riesgo…
Thyroid dysfunction is quite common during pregnancy, with TPO antibody (TPOAb) positivity occurring in roughly 10% of women of reproductive age. During pregnancy, subclinical hypothyroidism has a prevalence of about 3.5%.
Cuidado de la mujer sana: la evidencia de que menos es más Kenneth W. Lin, MD, MPH 17 de abril de 2019 Esta transcripción ha sido editada para mayor claridad.
The study, called the PARROT trial, is the first multicenter randomized controlled trial to evaluate the usefulness of PlGF testing added to traditional methods of diagnosis for preeclampsia. Results, published online April 1 in the Lancet, support the la
Cardiovascular disease (CVD) is the leading cause of death and disability among women, with more than half occurring in individuals with hypertension. New blood pressure criteria for the diagnosis of hypertension from the American College of Cardiology/Am